RA0096

antibody from Oursmab
Targeting: CD38
Provider product page for RA0096
Western blot
ELISA
Immunocytochemistry
Flow cytometry
Functional assay

Antibody data

Product number
RA0096 - Provider product page
Provider
Oursmab
Product name
Felzartamab (Biosimilar Reference Antibody) (CD38)
Antibody type
Monoclonal
Description
Felzartamab (development code MOR-202 or TJ-202) is an investigational, human monoclonal IgG1 antibody being developed for the treatment of relapsed or refractory multiple myeloma (RRMM). It functions as a targeted immunotherapy against a specific antigen highly expressed on malignant plasma cells. The antibody is engineered to bind with high affinity to its target on the surface of myeloma cells. Its primary anti-tumor mechanisms include antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP), whereby it recruits and activates immune effector cells (such as natural killer cells and macrophages) to attack and eliminate the targeted cancer cells. It may also have direct anti-proliferative effects.
Reactivity
Human
Isotype
IgG
Vial size
100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg
Concentration
Bottled at the concentration indicated on the vial.
Storage
Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.
CD38 protein structure - RA0096 shown in red.